Suppr超能文献

拉丁美洲多发性硬化症的遗传学

The genetics of multiple sclerosis in Latin America.

作者信息

Rivas Alonso Verónica, Flores Rivera José de Jesús, Rito García Yamel, Corona Teresa

机构信息

Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery "Dr Manuel Velasco Suárez", México.

出版信息

Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317727295. doi: 10.1177/2055217317727295. eCollection 2017 Jul-Sep.

Abstract

BACKGROUND

In today's globalised world, the heterogeneity of diseases such as multiple sclerosis has been studied since it has been suggested that ethnic differences, in conjunction with geographical and environmental factors, influence its incidence and prevalence.

AIM

Based on this, an attempt has been made to identify the genetic factors that may confer risk or protection, not only for developing multiple sclerosis but also for determining the course of its evolution.

RESULTS

In Latin America we have some data about this, which have been replicated in different populations in the entire region, with very different results compared with other regions, which could explain not only the different frequencies in some populations, such as Caucasians, but also the course of the disease and the response to actual treatments. However, in addition to these findings, other associated epigenetic mechanisms have also been found in our populations, such as levels of vitamin D, parasitic diseases, and indigenous populations. Therefore, the study of epigenetics plays a crucial role in understanding the physiopathology of multiple sclerosis. It must be studied in each population, especially in Latin America, due to its broad heterogeneity.

CONCLUSION

It is very important to understand not only the genetic and external factors with these very specific effects in multiple sclerosis patients, but also the way they interact and are able to explain the frequency and some specific phenotypes of the disease in our populations besides the posibility to be a very specific treatment target.

摘要

背景

在当今全球化的世界中,由于有人提出种族差异与地理和环境因素共同影响多发性硬化症等疾病的发病率和患病率,因此对其异质性进行了研究。

目的

基于此,人们试图确定不仅可能导致患多发性硬化症风险或提供保护,而且还能决定其演变过程的遗传因素。

结果

在拉丁美洲,我们有关于此的一些数据,这些数据已在该地区不同人群中得到重复验证,与其他地区相比结果差异很大,这不仅可以解释某些人群(如白种人)中不同的发病率,还能解释疾病的进程以及对现有治疗的反应。然而,除了这些发现之外,我们的人群中还发现了其他相关的表观遗传机制,如维生素D水平、寄生虫病和原住民。因此,表观遗传学研究在理解多发性硬化症的生理病理学方面起着至关重要的作用。由于拉丁美洲人群具有广泛的异质性,必须在每个群体中进行研究,尤其是在拉丁美洲。

结论

不仅要了解对多发性硬化症患者有这些非常特殊影响的遗传和外部因素,还要了解它们相互作用的方式,以及它们除了可能成为非常特殊的治疗靶点之外,还能够解释我们人群中疾病的发病率和一些特定表型,这一点非常重要。

相似文献

1
The genetics of multiple sclerosis in Latin America.
Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317727295. doi: 10.1177/2055217317727295. eCollection 2017 Jul-Sep.
2
Environmental factors influencing multiple sclerosis in Latin America.
Mult Scler J Exp Transl Clin. 2017 Jun 13;3(2):2055217317715049. doi: 10.1177/2055217317715049. eCollection 2017 Apr-Jun.
3
Evolution of multiple sclerosis prevalence and phenotype in Latin America.
Mult Scler Relat Disord. 2018 May;22:97-102. doi: 10.1016/j.msard.2018.03.014. Epub 2018 Mar 21.
4
Multiple sclerosis in Colombia and other Latin American Countries.
Mult Scler Relat Disord. 2013 Apr;2(2):80-9. doi: 10.1016/j.msard.2012.09.001. Epub 2012 Oct 24.
6
Prevalence of multiple sclerosis in Latin America and its relationship with European migration.
Mult Scler J Exp Transl Clin. 2016 Sep 2;2:2055217316666407. doi: 10.1177/2055217316666407. eCollection 2016 Jan-Dec.
7
Latitudinal prevalence gradient of multiple sclerosis in Latin America.
Mult Scler. 2011 Sep;17(9):1055-9. doi: 10.1177/1352458511405562. Epub 2011 May 6.
8
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Mult Scler. 2013 Jun;19(7):844-54. doi: 10.1177/1352458512462918. Epub 2012 Oct 8.
9
Multiple Sclerosis in Latin Americans: Genetic Aspects.
Curr Neurol Neurosci Rep. 2017 Aug;17(8):57. doi: 10.1007/s11910-017-0768-4.

引用本文的文献

1
Multiple Sclerosis Care in Latin America.
Int J MS Care. 2024 Dec 1;27(Theme):T7-T12. doi: 10.7224/1537-2073.2024-085. eCollection 2024 Dec.
2
Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.
J Mol Neurosci. 2020 Jan;70(1):26-31. doi: 10.1007/s12031-019-01395-9. Epub 2019 Aug 13.

本文引用的文献

1
Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults.
J Neuroimmunol. 2017 May 15;306:20-24. doi: 10.1016/j.jneuroim.2017.01.009. Epub 2017 Feb 3.
3
Neuromyelitis Optica (NMO IgG+) and Genetic Susceptibility, Potential Ethnic Influences.
Cent Nerv Syst Agents Med Chem. 2018 Jan 26;18(1):4-7. doi: 10.2174/1871524916666160229115047.
4
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.
Neurol Neuroimmunol Neuroinflamm. 2015 Dec 24;3(1):e192. doi: 10.1212/NXI.0000000000000192. eCollection 2016 Feb.
5
Presence of the HLADR13 allele among Mexican Mestizos suggests a protective factor against relapsing-remitting multiple sclerosis (RRMS).
Clin Neurol Neurosurg. 2015 Nov;138:184-7. doi: 10.1016/j.clineuro.2015.08.016. Epub 2015 Aug 31.
7
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
Neurologia. 2017 Sep;32(7):463-468. doi: 10.1016/j.nrl.2015.03.011. Epub 2015 May 12.
8
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
Mult Scler. 2016 Jan;22(1):126-7. doi: 10.1177/1352458515576986. Epub 2015 Mar 12.
9
Genomewide admixture study in Mexican Mestizos with multiple sclerosis.
Clin Neurol Neurosurg. 2015 Mar;130:55-60. doi: 10.1016/j.clineuro.2014.11.026. Epub 2014 Dec 24.
10
Epigenetic control of autoimmune diseases: from bench to bedside.
Clin Immunol. 2015 Mar;157(1):1-15. doi: 10.1016/j.clim.2014.12.013. Epub 2015 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验